Թϴͷ

Թϴͷ Announces Appointments of Corporate Officers

Listed Company Name: Թϴͷ Co., Ltd. 
Representative: Haruo Naito 
Representative Corporate Officer and CEO 
Securities Code: 4523

Stock Exchange Listings: Prime Market of the Tokyo Stock Exchange

Inquiries: Sayoko Sasaki
Vice President, Corporate Communications
Phone +81-3-3817-5120

 

Թϴͷ Co., Ltd. announced today that the following Corporate Officers, effective April 1, 2025, were appointed by resolutions at the subsequent Board of Directors meeting held today.

 

1. Corporate Officers

New Responsibility Name Current Responsibility
Representative Corporate Officer
CEO
Haruo Naito As on the left
Representative Corporate Officer
Industry Affairs
Yasushi Okada Representative Corporate Officer
Industry Affairs, China Business, Internal Audit
Representative Corporate Officer
Executive Vice President
COO, Chief Growth Officer
Keisuke Naito As on the left

Representative Corporate Officer
Executive Vice President
Chief Business Officer,
Chief IR Officer, Internal Audit, Japan Subsidiaries

Terushige Iike Executive Vice President
Chief Strategy and Planning Officer
Senior Vice President
President, EMEA Region,
Chairman & CEO, Թϴͷ Europe Ltd.
Gary Hendler As on the left
Senior Vice President
President, Americas Region,
Chairman & CEO, Թϴͷ Inc.
Tatsuyuki Yasuno As on the left
Senior Vice President
President, Թϴͷ China Holdings Ltd.
Yanhui Feng As on the left
Vice President
Chief Clinical Officer
Lynn Kramer As on the left
Vice President
China Business,
Japan / Asia Filing and Registration,
Global Safety
Sayoko Sasaki Vice President
Corporate Communications
Sustainability
Vice President
President, Asia and Latin America Region,
API Solutions
Shohei Kanazawa As on the left
Vice President
Manufacturing, Quality and Technology,
Japan Regulatory Affairs
Akiko Nakahama Vice President
Chief Portfolio Officer
Japan / Asia Filing and Registration
Chief Quality Officer
Japan Regulatory Affairs
Vice President
Chief HR Officer,
Corporate Communications,
Sustainability, General Affairs
Teruyuki Masaka Vice President
Chief HR Officer, General Affairs,
Japan Subsidiaries
Vice President
New Supply Chain Strategy
Mitsuo Kosaka As on the left
Vice President
Corporate Strategy
Shin Ujiie As on the left
Vice President
Business Development and Global Alliance
Toshitaka Asano As on the left
Vice President
Chief Financial Officer
Mitsuru Shomon As on the left
Vice President
Chief Information Officer
Makoto Hoketsu As on the left
Vice President
General Counsel,
Chief Compliance Officer,
Intellectual Property,
Internal Control
Shin Kato As on the left
Vice President
Japan Business
Toshihiko Yusa Group Officer
Deputy President and Թϴͷ Japan,
LEQEMBI Special Mission, Թϴͷ Japan
Vice President
Chief Scientific Officer
Katsutoshi Ido Discovery Strategy Councilor, DHBL HQs

NOTE: Representative Corporate Officer and CEO Haruo Naito will also serve concurrently as a Director. Representative Corporate Officer Yasushi Okada will retire from the post of Corporate Officer and be appointed as a Director of the company as of June 18, 2025.

 

2. Changes in Representative Corporate Officers

New Position Name Current Responsibility
Representative Corporate Officer,
Executive Vice President
Terushige Iike Executive Vice President
Chief Strategy and Planning Officer

 

3. Nominees for New Corporate Officers

New Position Name Current Responsibility
Vice President Toshihiko Yusa Group Officer
Deputy President and Թϴͷ Japan
LEQEMBI Special Mission, Թϴͷ Japan
Vice President Katsutoshi Ido Discovery Strategy Councilor, DHBL HQs

 

4. Retiring Corporate Officer

Name Current Responsibility
Masatomi Akana Senior Vice President
Chief Government Relations Officer,
Chief IR Officer
Takashi Owa Senior Vice President
Chief Scientific Officer
Japan Medical, Safety
Kazuhiko Tamura Vice President
President, Թϴͷ Demand Chain Systems

NOTE: Masatomi Akana, Takashi Owa and Kazuhiko Tamura are to be appointed as Senior Group Officers.

 

5. Career Summary of New Nominees for Corporate Officer

Toshihiko Yusa (April 3, 1968)

Apr. 1992      Joined Թϴͷ

Sep. 2014     Chief of Planning Department, Թϴͷ Japan

Apr. 2016      Chief of Regional Cooperation Tokai-Hokuriku HQ, Թϴͷ Japan

Oct. 2018      Chief of Executive Office Section

Jun. 2019      Chief of Regional Cooperation Shuto-Ken HQ, Թϴͷ Japan

Jan. 2020      Group Officer (Current)
                     AD Purpose Officer, Dementia Total Inclusive Ecosystem Business Unit

Jul.  2021      Chief of Integrated Dementia Strategy Department

Apr. 2024      Deputy President and Թϴͷ Japan LEQEMBI Special Mission, Թϴͷ Japan (Current)

 

Katsutoshi Ido (July 21, 1978)

Apr. 2003     Joined Թϴͷ

Apr. 2018     International Project Team Discovery Lead

Apr. 2020     Global Gene Therapy Task Force Lead, Discovery, Medicine Creation, Neurology Business Group

Jul.  2021     Global Modality Exploration Task Force Lead, Discovery, Medicine Creation, Neurology Business Group

Jul.  2022     (Secondees) Director of Cambridge Office, Թϴͷ Innovation Inc.

Apr. 2024     Head of InflammAging & Senescence Domain, DHBL

Oct. 2024     Discovery Strategy Councilor, DHBL HQs (Current)